Why is $ACET moving today? · SEC 8-K archive

$ACET SEC Filing Alert & Real-Time AI Stock Impact Analysis

T0 SEO archive for $ACET: filings appear instantly. AI score, direction and bullet analysis unlock publicly after 4 hours (VIP sees them live).

← All archive signals

FAQ: $ACET filing catalyst

Why did $ACET trigger an AI stock catalyst alert?

$ACET triggered a Stock Catalyst AI alert on 2026-11-05 00:00:00 UTC for a SEC 8-K filing (AI Score: +0.5/10). Headline: Adicet Bio Reports Reduced Q3 Net Loss, Advances Prula-Cel Program. Key points: - Q3 R&D expenses dropped to $15.6M vs $22.9M YoY; G&A reduced to $4.2M. - Net loss contracted to ~$18.8M ($1.76 per share) vs $26.8M ($4.72 per share) in Q3 2025. - Phase 1 follow-up data and regulatory discussions with the FDA expected late 2026/early 2027.

How did $ACET stock react after the SEC filing?

After the SEC 8-K for $ACET, observed market reaction: T0 price $2.92. Past moves do not guarantee future results.

Where can I get real-time $ACET SEC filing alerts?

Stock Catalyst AI pushes real-time SEC 8-K alerts for $ACET via Telegram and the VIP Web Terminal from €10/month.

$ACET

$ACET – Adicet Bio Reports Reduced Q3 Net Loss, Advances Prula-Cel Program

Adicet Bio, Inc.

2026-11-05 00:00:00 UTC · SEC 8-K · All $ACET

Unlocked archive · Analyzed in <2s at T0

Neutral AI Sentiment (+0.5 / 10)

Q3 R&D expenses dropped to $15.6M vs $22.9M YoY; G&A reduced to $4.2M.
Net loss contracted to ~$18.8M ($1.76 per share) vs $26.8M ($4.72 per share) in Q3 2025.
Phase 1 follow-up data and regulatory discussions with the FDA expected late 2026/early 2027.

Unlock Live VIP Terminal & Telegram – €10/mo Original filing →